Hataali 2.0 creates a single interoperable platform for the entire advanced therapy ecosystem
Hataali – the advanced therapy ecosystem platform – has announced the launch of Hataali 2.0. This second-generation platform will unlock the potential in the advanced therapies ecosystem by providing a plug and play approach for any stakeholder and almost any…
WHAT IS TARGETED THERAPY OR IMMUNOTHERAPY FOR PAEDIATRIC CANCERS?
The author of this article is Dr. Ruchira Misra, Sr. Consultant (Paediatric Haemato-Oncology and Bone Marrow Transplant), SRCC Children’s Hospital, managed by Narayana Health. Paediatric Oncology is a very fast developing and changing field due to ongoing research in the fields of…
Aster Medcity becomes the First Centre in South Asia to introduce NeuroNav MER system (Alpha Omega) in partnership with Medtronic for Deep Brain Stimulation (DBS) therapy done for Parkinson’s Disease patients.
Aster Medcity and India Medtronic Private Limited, a wholly owned subsidiary of Medtronic plc (NYSE: MDT), have partnered to build a comprehensive and advanced Deep Brain Stimulation (DBS) program for Parkinson’s patients in India. The partnership supports the Aster Centre…